PMID- 20546002
OWN - NLM
STAT- MEDLINE
DCOM- 20110325
LR  - 20161125
IS  - 1540-8175 (Electronic)
IS  - 0742-2822 (Linking)
VI  - 27
IP  - 7
DP  - 2010 Aug
TI  - Immediate and follow-up results of repeat percutaneous mitral balloon 
      commissurotomy for restenosis after a succesful first procedure.
PG  - 765-9
LID - 10.1111/j.1540-8175.2010.01150.x [doi]
AB  - BACKGROUND: The widespread use of percutaneous mitral commissurotomy (PMC) has 
      led to an increase in restenosis cases. The data regarding follow-up results of 
      repeat PMC are quite limited. The aim of this retrospective analysis is to 
      evaluate the immediate and midterm results of the second PMC, in patients with 
      symptomatic mitral restenosis after a succesful first procedure. METHODS: Twenty 
      patients (95% female, mean age 37 +/- 4 years) who have undergone a second PMC, 6.3 
      +/- 2.5 years after a first successful intervention built the study group. All were 
      in sinus rhythm, with a mean Wilkins score of 8.5 +/- 1.2. RESULTS: The valve area 
      increased from 1.2 +/- 0.2 to 1.9 +/- 0.2 cm(2) and mean gradient decreased from 10.5 
      +/- 3.4 to 6.1 +/- 1.1 mmHg. There were no complications except for a transient 
      embolic event without sequela (5%) and two cases (10%) of severe mitral 
      regurgitation. The immediate success rate was 90%. The mean follow-up was 70 +/- 29 
      months (36-156 months). The 5-year restenosis and intervention (repeat PMC or 
      valve replacement) rates were 9.1 +/- 5.2% and 3.6 +/- 3.3%, respectively. The 
      intervention free 5-year survival in good functional capacity (New York Heart 
      Association [NYHA] I-II) was 95.1 +/- 5.5% and restenosis and intervention free 
      5-year survival with good functional capacity was 89.7 +/- 6.8%. CONCLUSIONS: 
      Although from a limited number of selected patients, these findings indicate that 
      repeat PMC is a safe and effective method, with follow-up results similar to a 
      first intervention and should be considered as the first therapeutic option in 
      suitable patients.
CI  - (c) 2010, Wiley Periodicals, Inc.
FAU - Yazicioglu, Nuran
AU  - Yazicioglu N
AD  - Department of Cardiology, Institute of Cardiology, Istanbul University, Istanbul, 
      Turkey.
FAU - Arat Ozkan, Alev
AU  - Arat Ozkan A
FAU - Orta Kilickesmez, Kadriye
AU  - Orta Kilickesmez K
FAU - Celiker, Cengiz
AU  - Celiker C
FAU - Mert, Murat
AU  - Mert M
FAU - Pehlivanoglu, Seckin
AU  - Pehlivanoglu S
FAU - Enar, Rasim
AU  - Enar R
FAU - Karatay, Canan
AU  - Karatay C
FAU - Kucukoglu, Serdar
AU  - Kucukoglu S
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Echocardiography
JT  - Echocardiography (Mount Kisco, N.Y.)
JID - 8511187
SB  - IM
MH  - Adult
MH  - Angioplasty, Balloon/*statistics & numerical data
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - Mitral Valve Stenosis/diagnostic imaging/*epidemiology/*therapy
MH  - Reoperation/statistics & numerical data
MH  - Risk Assessment
MH  - Risk Factors
MH  - Treatment Outcome
MH  - Turkey
MH  - Ultrasonography
EDAT- 2010/06/16 06:00
MHDA- 2011/03/26 06:00
CRDT- 2010/06/16 06:00
PHST- 2010/06/16 06:00 [entrez]
PHST- 2010/06/16 06:00 [pubmed]
PHST- 2011/03/26 06:00 [medline]
AID - ECHO1150 [pii]
AID - 10.1111/j.1540-8175.2010.01150.x [doi]
PST - ppublish
SO  - Echocardiography. 2010 Aug;27(7):765-9. doi: 10.1111/j.1540-8175.2010.01150.x.